Merlin Capital’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$675K Buy
28,444
+3,861
+16% +$85.8K 2.01% 28
2023
Q4
$590K Sell
24,583
-58
-0.2% -$1.26K 1.89% 28
2023
Q3
$538K Sell
24,641
-1,122
-4% -$23.5K 2.01% 24
2023
Q2
$492K Hold
25,763
1.67% 36
2023
Q1
$500K Buy
25,763
+15
+0.1% +$261 1.81% 30
2022
Q4
$413K Buy
25,748
+866
+3% +$14.1K 1.02% 49
2022
Q3
$390K Sell
24,882
-841
-3% -$16.2K 0.9% 49
2022
Q2
$536K Sell
25,723
-536
-2% -$11K 1.07% 38
2022
Q1
$595K Buy
+26,259
New +$513K 0.79% 46

Other funds holding EXEL

Merlin Capital's EXEL Position: Q1 2024 in Review

Merlin Capital increased its Exelixis (EXEL) stake by 16% in Q1 2024, buying an estimated $85.8K and bringing the position to 28,444 shares worth $675K. The position accounts for 2.01% of the portfolio, ranked #28.

Merlin Capital first reported a position in EXEL in Q1 2022 and has held it in 9 quarters since. 422 funds tracked by Wall St. Rank hold EXEL as of Q1 2024.

  • Merlin Capital held 28,444 shares of Exelixis worth $675K as of Q1 2024.
  • Merlin Capital bought 3,861 Exelixis shares in Q1 2024, an estimated $85.8K.
  • Exelixis made up 2.01% of Merlin Capital's portfolio in Q1 2024, its #28 holding.
  • Merlin Capital first reported a position in Exelixis in Q1 2022 and has held it in 9 quarters since.
  • 422 funds tracked by Wall St. Rank held Exelixis as of Q1 2024.

Based on Merlin Capital's 13F filing for Q1 2024, filed 13 May 2024.